The global sleep apnea devices market size was valued at USD 5.1 billion in 2025 and is projected to grow from USD 5.4 billion in 2026 to USD 8.4 billion by 2033, registering a CAGR of 6.6% from 2026 to 2033. North America dominated the global market in 2025, accounting for a revenue share of 47.6%. Market growth is primarily driven by the rising prevalence of obstructive sleep apnea (OSA), an aging global population, increasing awareness of sleep-related disorders, and technological advancements in sleep apnea treatment devices.

According to the National Council on Aging (NCOA), as of October 2023, approximately 39 million adults in the U.S. and 936 million adults worldwide were affected by obstructive sleep apnea. OSA is characterized by repeated interruptions in breathing during sleep, which can reduce oxygen supply to the brain and contribute to various health complications. The growing disease burden is increasing the demand for effective diagnostic and therapeutic solutions worldwide.

Sleep Apnea Devices Market Overview

The global sleep apnea devices market is experiencing steady growth due to the increasing prevalence of obstructive sleep apnea, rising demand for continuous positive airway pressure (CPAP) therapy, and growing adoption of home-based treatment solutions. Technological advancements, including wearable sleep monitoring technologies, advanced respiratory devices, and implantable treatment systems, are further supporting market expansion.

Grand View Research estimates that the global sleep apnea devices market will increase from USD 5.1 billion in 2025 to USD 8.4 billion by 2033, registering a CAGR of 6.6% during the forecast period. North America accounted for the largest revenue share in 2025, while Asia Pacific is anticipated to register the fastest growth through 2033.

Go Deeper! Ask Prism AI

about the Global sleep apnea devices market. Get instant answers to questions related to market sizing, growth drivers & their impact, and more.

Key Market Trends & Insights

• By product type: The therapeutic devices segment dominated the market, accounting for 78.6% of the global revenue share in 2025. The segment's leadership is supported by the widespread use of CPAP devices, bilevel positive airway pressure (BiPAP) devices, and other therapeutic solutions for managing sleep apnea.
• By end use: The home care segment held the largest market share in 2025, driven by increasing patient preference for convenient, long-term sleep apnea management outside traditional healthcare facilities.
• By region: North America dominated the global market with a revenue share of 47.6% in 2025.
• Fastest-growing region: Asia Pacific is expected to register the highest CAGR from 2026 to 2033, supported by increasing awareness, improving healthcare infrastructure, and a growing patient population.
• By country: The U.S. accounted for the largest country-level market share in 2025.

Sleep Apnea Devices Market Size & Forecast, 2025–2033

Download a free sample report or claim your copy of this full market intelligence report

Sleep Apnea Devices Market Growth Drivers

Rising Prevalence of Obstructive Sleep Apnea and Growing Geriatric Population

The increasing prevalence of obstructive sleep apnea (OSA) worldwide is a major factor driving the growth of the sleep apnea devices market. The condition is particularly common among older adults and frequently remains undiagnosed due to limited awareness, nonspecific symptoms, and inadequate screening. The growing global geriatric population is consequently creating a larger patient base requiring sleep apnea diagnosis, treatment, and long-term respiratory support.

According to global aging projections, the population aged 60 years and above is expected to reach approximately 2 billion by 2050. Its share of the global population is projected to increase from 12% to 22%. Furthermore, OSA affects an estimated 13% to 32% of individuals aged 65 years and above, highlighting the increasing need for effective sleep disorder management solutions.

The growing vulnerability of older adults to sleep-related breathing disorders is expected to support the adoption of CPAP machines, oxygen therapy equipment, and other sleep apnea treatment devices. According to information reported to the U.S. Securities and Exchange Commission, more than 8 million CPAP interfaces are sold annually in the U.S., with an additional 2.5 million units sold globally. These figures highlight the substantial demand for CPAP-related products and replacement accessories.

Technological Advancements and Introduction of Innovative Treatment Solutions

Technological innovation and the entry of new market participants are contributing to the development of advanced sleep apnea treatment solutions. Manufacturers are increasingly focusing on improving device performance, patient comfort, treatment adherence, and ease of use. Innovations in connected respiratory devices, wearable monitoring systems, and minimally invasive treatment technologies are expanding the range of available treatment options.

For instance, the FDA-approved Inspire implant offers an alternative treatment approach for certain patients with obstructive sleep apnea. The implant uses hypoglossal nerve stimulation to help maintain an open airway during sleep, addressing airway obstruction through an internal therapeutic mechanism rather than conventional external positive airway pressure delivery.

The growing availability of alternative treatment technologies is expected to improve patient access to personalized therapies and create additional growth opportunities for sleep apnea device manufacturers.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.

Sleep Apnea Devices Market Dynamics

Key Market Driver: Increasing Global Burden of Obstructive Sleep Apnea

The rising global burden of obstructive sleep apnea remains one of the strongest growth drivers for the sleep apnea devices market. OSA is increasingly associated with obesity, diabetes, cardiovascular diseases, aging, and sedentary lifestyles. These risk factors are expanding the population requiring sleep disorder screening, diagnosis, and long-term treatment.

According to an August 2025 article published by ResMed Inc., the number of adults in the U.S. diagnosed with obstructive sleep apnea is projected to reach nearly 77 million by 2050, representing a 35% increase from 2020 levels. The condition is expected to affect approximately 46% of adults aged 30–69 years.

These projections are based on an open-cohort dynamic population model that considers changes in age, sex, and body mass index (BMI). Increasing obesity rates and demographic changes are among the major factors contributing to the anticipated rise in OSA cases.

The growing patient population is expected to increase demand for CPAP machines, BiPAP devices, oral appliances, and other sleep apnea treatment technologies. In addition, awareness campaigns, improved screening initiatives, and advancements in diagnostic technologies are helping identify previously undiagnosed patients, further supporting market growth.

Key Sleep Apnea Devices Companies

The global sleep apnea devices market comprises established medical device manufacturers and emerging technology providers focusing on product innovation, distribution expansion, and advanced respiratory care solutions.

The following companies have been profiled in the Grand View Research study:

1. ResMed
2. Respironics (a subsidiary of Koninklijke Philips N.V.)
3. Fisher & Paykel Healthcare Limited
4. Curative Medical, Inc.
5. React Health (Respiratory Product Line from Invacare Corporation)
6. Somnetics International, Inc.
7. BMC Medical Co., Ltd.
8. Natus Medical Incorporated
9. SOMNOmedics GmbH
10. Compumedics
11. Itamar Medical Ltd.
12. Nihon Kohden Corporation

Explore our dedicated business services:

U.S. Healthcare Facility Mapping & Intelligence Platform: Get facility-level intelligence to guide smarter decisions. Sign up Today